Ralph G. Neas

Consumer Services

Commercial Services

Profile

Mr. Ralph G.
Neas is President & Chief Executive Officer at Generic Pharmaceutical Association.
He received his undergraduate degree from the University of Notre Dame and a graduate degree from The University of Chicago.

Former positions of Ralph G. Neas

Companies	Position	End
Association for Accessible Medicines Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.	Chief Executive Officer	18/08/2015

See the detail of Ralph G. Neas's experience

Training of Ralph G. Neas

University of Notre Dame	Undergraduate Degree
The University of Chicago	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ralph G. Neas's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Association for Accessible Medicines Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.	Commercial Services